Navigation Links
Magnesium sulfate offers no help in migraine treatment

Addition of intravenous magnesium sulfate to standard emergency department migraine therapy with metoclopramide, appears to reduce rather than enhance the effectiveness of treatment.// Dr. Jill Corbo, and colleagues from the Albert Einstein College of Medicine in the Bronx, New York, note that there is evidence that magnesium may be helpful in the treatment of migraine headache and that studies in other applications, including asthma treatment, have shown that magnesium sulfate infusions are well tolerated.

To investigate whether such an infusion might be an effective adjunct to migraine therapy, the researchers conducted a double-blind study of 44 patients seeking emergency department migraine treatment.

The subjects, 42 of whom were women, were randomized to receive intravenously 20 mg of metoclopramide and 2 g of magnesium sulfate or 20 mg of metoclopramide and saline placebo at 15-minute intervals. The infusion was stopped after a maximum of three doses or when pain relief was obtained. Examination of visual analogue pain scores demonstrated that those in the placebo group showed greater pain reduction than those in the magnesium group.//

Commenting on this unexpected finding, Dr. Corbo told that "our study showed that the addition of magnesium to the standard therapy of metoclopramide may reduce the effectiveness of metoclopramide in relieving migraine." However, she added that "because 95% of the patients were women, the data may not be generalizable to men."


'"/>




Page: 1

Related medicine news :

1. Magnesium no benefit of survival after heart attack
2. Magnesium In Diet Strengthens Bones
3. Magnesium Levels to Detect the Outcome of Brain Injury
4. Improved Wheats Could Reduce Magnesium Deficiencies: Research
5. Magnesium Supplements for Strong-boned Girls
6. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
7. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
8. ESRC offers new dynamics for old in UK
9. Roche offers HIV drug expertise to poor nations
10. Genetically modified Lactic acid bacteria offers HIV protection
11. SRL Ranbaxy offers quicker bird flu diagnostic test
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... April 29, 2016 , ... A new ... with severe congenital diaphragmatic hernia have better survival rates if surgery is performed ... (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs into ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... won the $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan ... the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ ...
(Date:4/29/2016)... NY (PRWEB) , ... April 29, 2016 , ... ... and engineer of patented products, announces the Gyrociser, an exercise invention which aids ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about ... of skin cancer deaths. More than 10,000 people are expected to die of melanoma this ... it is the one of the most commonly diagnosed cancers in young women. A recent ...
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
(Date:4/27/2016)... , April 27, 2016 ... Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor ... announced its sales for the first quarter ended March ... and the execution of its commercial strategy. ...
Breaking Medicine Technology: